Digraph

2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Studyhttps://www.atsjournals.org/doi/10.1164/rccm.202001-0135OC
2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
New generation of drugs show early efficacy against drug-resistant TB -- ScienceDailyhttps://www.sciencedaily.com/releases/2020/08/200812161316.htm
2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
New generation of drugs show early efficacy against drug-resistant TB https://bit.ly/33S8Fgr via @HarvardMed @EurekAlerthttps://twitter.com/SaskiaPopescu/status/1293892655168942080
2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
New generation of drugs show early efficacy against drug-resistant TB | EurekAlert! Science Newshttps://www.eurekalert.org/pub_releases/2020-08/hms-ngo081220.php
2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
Promising Progress | Harvard Medical Schoolhttps://hms.harvard.edu/news/promising-progress
2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study

Showing topic

2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
BedaquilineDelamanidMultidrug-resistant tuberculosis (MDR-TB)